Abstract
Human telomerase reverse transcriptase, hTERT, is the catalytic component of human telomerase. Expression of hTERT confers telomerase activity, indicating that hTERT is the rate-limiting component of human telomerase. Here we report the detection of anti-hTERT auto-antibodies in the sera derived patients with hepatocellular carcinoma using recombinant, purified hTERT as an antigen in an enzyme linked immunosorbent assay (ELISA). The levels of anti-hTERT antibodies in serum correlated with progression to hepatocellular carcinoma. In contrast, we detected only low levels of anti-hTERT auto-antibodies in the sera derived from 18 normal volunteers. The observation of hTERT auto-antibodies in the sera derived from cancer patients suggests that such auto-antibodies constitute novel and specific tumor marker.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Arai K, Masutomi K, Khurts S, Kaneko S, Kobayashi K, Murakami S . 2002 J. Biol. Chem. 277: 8538–8544
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE . 1998 Science 279: 349–352
Covini G, Chan EK, Nishioka M, Morshed SA, Reed SI, Tan EM . 1997 Hepatology 25: 75–80
Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA . 2001 Genes Dev. 15: 50–65
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . 1999 Nature 400: 464–468
Hiyama E, Hiyama K . 2002 Oncogene 21: 643–649
Imai H, Chan EK, Kiyosawa K, Fu XD, Tan EM . 1993a J. Clin. Invest. 92: 2419–2426
Imai H, Nakano Y, Kiyosawa K, Tan EM . 1993b Cancer 71: 26–35
Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM . 1992 Am. J. Pathol. 140: 859–870
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015
Kitamoto M, Ide T . 1999 Cancer 85: 245–248
Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M . 1997 Gastroenterology 112: 493–500
Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL . 1998 Nat. Genet. 19: 182–186
Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S . 2000 J. Biol. Chem. 275: 22568–22573
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T, Ishikawa F . 1998 Nat. Genet. 18: 65–68
Nelson DS . 1977 Pathology 9: 155–160
Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T . 1996 Cancer 78: 232–236
Saeboe-Larssen S, Fossberg E, Gaudernack G . 2002 J. Immunol. Methods 259: 191–203
Schattner A, Shani A, Talpaz M, Bentwich Z . 1983 Cancer 52: 2156–2161
Shay JW, Wright WE . 1996 Trends Genet. 12: 129–131
Tan EM . 1991 Cell 67: 841–842
Treon SP, Raje N, Anderson KC . 2000 Semin. Oncol. 27: 598–613
Vonderheide RH . 2002 Oncogene 21: 674–679
Vonderheide RH, Schultze JL, Anderson KS, Maecker B, Butler MO, Xia Z, Kuroda MJ, von Bergwelt-Baildon MS, Bedor MM, Hoar KM, Schnipper DR, Brooks MW, Letvin NL, Stephans KF, Wucherpfennig KW, Hahn WC, Nadler LM . 2001 Cancer Res. 61: 8366–8370
Wasserman J, Glas U, Blomgren H . 1975 Clin. Exp. Immunol. 19: 417–422
Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP . 1992 Cancer Res. 52: 4168–4174
Acknowledgements
We thank Dr T Yamashita for critical comments and Ms K Kuwabara for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masutomi, K., Kaneko, S., Yasukawa, M. et al. Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma. Oncogene 21, 5946–5950 (2002). https://doi.org/10.1038/sj.onc.1205788
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1205788
Keywords
This article is cited by
-
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis
International Journal of Clinical Oncology (2011)
-
Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates
Molecular Therapy (2009)
-
Analysis of hTERT mRNA expression in biliary tract and pancreatic cancer
Journal of Hepato-Biliary-Pancreatic Surgery (2007)